Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Pregnancy and Vaccination








Tdap (Pertussis) Vaccine and Pregnancy						Print
																Related Pages
										Pertussis is on the rise and outbreaks are happening across the United States. On average, about 1,000 infants are hospitalized and typically between five and 15 infants die each year in the United States due to pertussis. Most of these deaths are among infants who are too young to be protected by the childhood pertussis vaccine series that starts when infants are 2 months old.
These first few months of life are when infants are at the greatest risk of contracting pertussis and having severe, potentially life-threatening complications from the infection. To help protect babies during this time when they are most vulnerable, women should get the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) during **each** pregnancy. A strong recommendation from you may be what most influences whether or not your patient’s newborn is protected against pertussis.
5 Facts about Tdap and Pregnancy
**Tdap during pregnancy provides the best protection for mother and infant.**
Recommend and administer or refer your patients to receive Tdap during every pregnancy.
Optimal timing is between 27 and 36 weeks gestation (preferably during the earlier part of this period) to maximize the maternal antibody response and passive antibody transfer to the infant.
Fewer babies will be hospitalized for and die from pertussis when Tdap is given during pregnancy rather than during the postpartum period.
**Postpartum Tdap administration is NOT optimal.**
Postpartum Tdap administration does not provide immunity to the infant, who is most vulnerable to the disease’s serious complications.
Infants remain at risk of contracting pertussis from others, including siblings, grandparents, and other caregivers.
It takes about 2 weeks after Tdap receipt for the mother to have protection against pertussis, which means the mother is still at risk for catching and spreading the disease to her newborn baby during this time.
**Cocooning alone may not be effective and is hard to implement.**
The term “cocooning” means vaccinating anyone who comes in close contact with an infant.
Cocooning is difficult and it can be costly to make sure that everyone who is around an infant is vaccinated.
**Tdap should NOT be offered as part of routine preconception care.**
Protection from pertussis vaccines does not last as long as vaccine experts would like, so Tdap is recommended during pregnancy in order to provide optimal protection to the infant.
If Tdap is administered at a preconception visit, it should be administered again during pregnancy between 27 and 36 weeks gestation.
**Tdap can be safely administered earlier in pregnancy if needed.**
Pregnant women should receive Tdap anytime during pregnancy if it is indicated for wound care or during a community pertussis outbreak.
If Tdap is administered earlier in pregnancy, it should not be repeated between 27 and 36 weeks gestation; only one dose is recommended during each pregnancy.Top of PageRelated PagesTdap (Tetanus, Diphtheria, Pertussis) VIS
The Pink Book – Pertussis
							
					
							Last Reviewed:  August 10, 2017						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeToolkit for Prenatal Care Providers
Why Maternal Vaccines Are Importantplus icon
Tdap (Pertussis) Vaccine and Pregnancy
Influenza (Flu) Vaccine and Pregnancy
Guidelines for Vaccinating Pregnant Women
Recommended Immunization Schedules for Adults
Research on Maternal Immunizationplus icon
Tdap Vaccine and Pregnancy Research
Flu Vaccine and Pregnancy Research
Implementation Resourcesplus icon
Standards for Adult Immunization Practice
Strategies for Increasing Adult Vaccination Rates
Getting Reimbursed for Tdap Vaccination
Resources for Provider Educationplus icon
Talking to Your Pregnant Patients about Vaccines
Print and Web Materials
Making a Strong Referral
Encouraging Your Practice to Improve Maternal Vaccination
Resources for Patient Education Vaccines & Immunizations
For Parents: Vaccines for Your Children
CDC’s Main Pregnancy Page
Zika and Pregnancy
 
 Medscape 
  CDC Commentary: Protect Patients From Deadly Pertussis: Updated Vaccine GuidelinesVideo: 5:59 minutes
Tami Skoff, MS, explains the latest vaccine recommendations for preventing pertussis from infancy through adulthood.“MEDSCAPE ACCOUNT NEEDED TO VIEW VIDEO”


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue